Claude Labrie Selected Research

ritetronium

3/2004	Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer.
5/2002	Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claude Labrie Research Topics

Disease

11	Prostatic Neoplasms (Prostate Cancer) 05/2014 - 02/2002
10	Atrophy 09/2015 - 09/2008
7	Neoplasms (Cancer) 04/2009 - 02/2002
6	Breast Neoplasms (Breast Cancer) 09/2008 - 05/2002
3	Pain (Aches) 09/2015 - 09/2009
2	Dyspareunia 09/2015 - 07/2014
2	Uterine Neoplasms (Uterine Cancer) 01/2009 - 05/2002
1	Carcinogenesis 01/2007
1	Adenocarcinoma 01/2007
1	Prostatic Diseases 01/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2007
1	Prostatic Intraepithelial Neoplasia 01/2007
1	Neoplasm Metastasis (Metastasis) 12/2004
1	Osteoporosis 05/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2002

Drug/Important Bio-Agent (IBA)

11	Dehydroepiandrosterone (DHEA)IBA 09/2015 - 04/2003
10	AndrogensIBA 09/2009 - 02/2002
7	Estrogens (Estrogen)FDA Link 07/2014 - 12/2004
5	Proteins (Proteins, Gene)FDA Link 02/2008 - 02/2002
4	SteroidsIBA 07/2014 - 10/2003
4	Transcription Factors (Transcription Factor)IBA 05/2014 - 02/2002
3	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2004 - 05/2002
2	Androgen Receptors (Androgen Receptor)IBA 01/2007 - 02/2002
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2005 - 12/2004
2	Androgen Antagonists (Antiandrogens)IBA 05/2005 - 12/2004
2	Selective Estrogen Receptor Modulators (SERM)IBA 03/2004 - 01/2003
2	Tamoxifen FDA LinkGeneric 03/2004 - 05/2002
2	ritetroniumIBA 03/2004 - 05/2002
2	EM 800IBA 03/2004 - 01/2003
1	Calcimycin (A23187)IBA 05/2014
1	Pharmaceutical PreparationsIBA 05/2014
1	Testosterone (Sustanon)FDA Link 11/2013
1	Myosin-Light-Chain KinaseIBA 04/2009
1	Biological ProductsIBA 06/2007
1	LigandsIBA 06/2007
1	Estrogen Receptor betaIBA 01/2007
1	bicalutamide (Casodex)FDA LinkGeneric 12/2004
1	nilutamide (Nilandron)FDA Link 12/2004
1	Flutamide (Eulexin)FDA LinkGeneric 12/2004
1	antineoplaston A10 (A 10)IBA 12/2004
1	Estrogen ReceptorsIBA 03/2004
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2004
1	AntigensIBA 10/2003
1	Dehydroepiandrosterone SulfateIBA 10/2003
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 05/2003
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2003
1	Peptide Hydrolases (Proteases)FDA Link 03/2003
1	Bone Morphogenetic Protein ReceptorsIBA 01/2003
1	Amino Acids FDA Link 01/2003
1	enhanced green fluorescent proteinIBA 01/2003
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2003
1	Raloxifene Hydrochloride (Evista)FDA Link 05/2002
1	Toremifene (Fareston)FDA Link 05/2002
1	idoxifeneIBA 05/2002
1	3- (4- (1,2- diphenylbut- 1- enyl)phenyl)acrylic acidIBA 05/2002
1	LipidsIBA 05/2002
1	droloxifeneIBA 05/2002
1	Estrone FDA Link 05/2002
1	Messenger RNA (mRNA)IBA 02/2002
1	Complementary DNA (cDNA)IBA 02/2002

Therapy/Procedure

4	Therapeutics 05/2005 - 01/2003
3	Intravaginal Administration 05/2015 - 09/2008
2	Castration 05/2005 - 12/2004
1	Life Support Care 12/2004
1	Ovariectomy (Oophorectomy) 01/2003
1	Radiotherapy 01/2003
1	Chemoprevention 05/2002